We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$6.86B
AUM Growth
-$3.41B
Cap. Flow
-$3.78B
Cap. Flow %
-55.19%
Top 10 Hldgs %
25.96%
Holding
2,871
New
973
Increased
552
Reduced
524
Closed
811

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$378M
2
AMZN icon
Amazon
AMZN
+$336M
3
AAPL icon
Apple
AAPL
+$294M
4
BABA icon
Alibaba
BABA
+$258M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$136M

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Consumer Discretionary 8.02%
3 Utilities 7.46%
4 Healthcare 7.42%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADVM
2076
DELISTED
Adverum Biotechnologies
ADVM
-1,211
Closed -$131K
AFMD
2077
DELISTED
Affimed
AFMD
-4,186
Closed -$244K
AFYA icon
2078
Afya
AFYA
$1.26B
-14,086
Closed -$356K
AGYS icon
2079
Agilysys
AGYS
$3.21B
-7,638
Closed -$293K
AHCO icon
2080
AdaptHealth
AHCO
$751M
-23,139
Closed -$869K
AIG icon
2081
American International
AIG
$40.5B
-29,114
Closed -$1.1M
AIZ icon
2082
Assurant
AIZ
$14.2B
-2,199
Closed -$300K
ALC icon
2083
Alcon
ALC
$35.6B
-28,297
Closed -$1.87M
ALEC icon
2084
Alector
ALEC
$257M
-15,982
Closed -$242K
ALLT icon
2085
Allot
ALLT
$369M
-44,400
Closed -$467K
ALV icon
2086
Autoliv
ALV
$9.02B
-42,412
Closed -$3.91M
AMKR icon
2087
Amkor Technology
AMKR
$11.9B
-45,548
Closed -$687K
AMWL icon
2088
American Well
AMWL
$203M
-3,665
Closed -$1.86M
AMZN icon
2089
PUT
Amazon
AMZN
$2.83T
-2,420,000
Closed -$394M
ANF icon
2090
Abercrombie & Fitch
ANF
$4.99B
-60,176
Closed -$1.23M
ANGO icon
2091
AngioDynamics
ANGO
$652M
-25,924
Closed -$397K
AOS icon
2092
A.O. Smith
AOS
$8.52B
-36,972
Closed -$2.03M
AOUT icon
2093
American Outdoor Brands
AOUT
$142M
-10,200
Closed -$174K
APD icon
2094
Air Products & Chemicals
APD
$68.2B
-43,443
Closed -$11.9M
APEI icon
2095
American Public Education
APEI
$846M
-10,388
Closed -$317K
APT icon
2096
Alpha Pro Tech
APT
$53.3M
-28,879
Closed -$322K
AR icon
2097
Antero Resources
AR
$11.7B
-31,780
Closed -$173K
ARCT icon
2098
Arcturus Therapeutics
ARCT
$408M
-23,302
Closed -$1.01M
ARDX icon
2099
Ardelyx
ARDX
$966M
-34,082
Closed -$221K
ARKG icon
2100
CALL
ARK Genomic Revolution ETF
ARKG
$1.89B
-9,800
Closed -$914K

Similar funds

Michael Gelband's Q1 2021 Portfolio in Review

As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.

Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.

  • Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
  • Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
  • Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
  • Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
  • Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
  • Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
  • Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.